key: cord-0906706-e9l2ngzj
authors: Yang, Yang; Yang, Minghui; Yuan, Jing; Wang, Fuxiang; Wang, Zhaoqin; Li, Jinxiu; Zhang, Mingxia; Xing, Li; Wei, Jinli; Peng, Ling; Wong, Gary; Zheng, Haixia; Wu, Weibo; Shen, Chenguang; Liao, Mingfeng; Feng, Kai; Li, Jianming; Yang, Qianting; Zhao, Juanjuan; Liu, Lei; Liu, Yingxia
title: Comparative sensitivity of different respiratory specimen types for molecular diagnosis and monitoring of SARS-CoV-2 shedding in COVID-19 patients
date: 2020-11-04
journal: Innovation (N Y)
DOI: 10.1016/j.xinn.2020.100061
sha: b2129503c050ed32966e9e2141352ee0d05a69c4
doc_id: 906706
cord_uid: e9l2ngzj

The global pandemic of Coronavirus Disease 2019 (COVID-19) is now ongoing. Rapid and accurate detection of the causative virus SARS-CoV-2 is vital for the treatment and control of COVID-19. In this study, the comparative sensitivity of different respiratory specimens were retrospectively analyzed using 3552 clinical samples from 410 Guangdong CDC (Center for Disease Control and Prevention) confirmed COVID-19 patients. Except for BALF, the sputum possessed the highest positive rate (73.4%∼87.5%), followed by nasal swabs (53.1%∼85.3%) for both severe and mild cases during the first 14 days after illness onset (d.a.o). Viral RNA could be detected in all BALF from the severe group collected as early as 4 days after illness onset (d.a.o) and lasted up to 46 d.a.o., while none of BALF samples from mild group. Moreover, although viral RNA was negative in the upper respiratory samples, it was also positive in BALF samples in most cases from severe group during treatment. Despite of typical ground-glass opacity observed via computed tomographic (CT) scans, no viral RNA was detected in the first 3 or all upper respiratory tract specimens from some COVID-19 patients. In conclusion, sputum is most sensitive for routine laboratory diagnosis of COVID-19, followed by nasal swabs. Detection of viral RNAs in BLAF improves diagnostic accuracy in severe COVID-19 patients.

of SARS-CoV-2 7-10 . More importantly, asymptomatic cases could also transmit the 28 virus to close contacts, which makes it more difficult to control the spread of the 29 virus 9 . Therefore, rapid and accurate detection of the causative virus SARS-CoV-2 is 30 vital for the control and treatment of COVID-19 11 . 31 In the early stage of the disease outbreak, diagnosis of the cases was mostly from 32 the lower respiratory tract specimens (usually broncho alveolar lavage fluid, BALF) 5 . 33 However, collection of the lower respiratory samples requires both a suction device 34 and a skilled operator, which is also a painful process for the patients. of the first specimen was 6 and 5 for the severe and mild groups, respectively (Table   58 1). The median number of specimens collected from each patient was 10 and 7 for the 59 severe and mild groups, respectively (Table 1) . 

A Novel Coronavirus 226 from Patients with Pneumonia in China

A novel coronavirus 229 genome identified in a cluster of pneumonia cases-Wuhan

Clinical findings in 232 a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) 233 outside of Wuhan, China: retrospective case series

Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia 237 in Wuhan, China

Clinical features of 239 patients infected with 2019 novel coronavirus in Wuhan

Clinical 242 Characteristics of Coronavirus Disease 2019 in China

A familial cluster of 245 pneumonia associated with the 2019 novel coronavirus indicating 246 person-to-person transmission: a study of a family cluster

Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

MERS coronavirus: diagnostics, epidemiology 268 and transmission

Laboratory 271 diagnosis of SARS. Emerg Infect Dis

Molecular and 273 serological investigation of 2019-nCoV infected patients: implication of 274 multiple shedding routes. Emerg Microbes Infect

Fecal specimen diagnosis 2019 novel 276 coronavirus-infected pneumonia

Evidence for Infect Dis

Persistent shedding of 290 viable SARS-CoV in urine and stool of SARS patients during the convalescent 291 phase

The Time Sequences of Oral 293 and Fecal Viral Shedding of Coronavirus Disease 2019 (COVID-19) Patients

Pathological evidence for 296 residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient

Middle 299 East respiratory syndrome coronavirus: another zoonotic betacoronavirus 300 causing SARS-like disease

Severe acute respiratory 302 syndrome coronavirus as an agent of emerging and reemerging infection

Temporal dynamics in 305 viral shedding and transmissibility of COVID-19

Clinical course and risk factors 308 for mortality of adult inpatients with COVID-19 in Wuhan, China: a 309 retrospective cohort study

Days after illness onset

COVID-19: Coronavirus disease 2019. yr: Years of age. IQR: Inter-quartile range

Table 2. Detection of SARS-CoV-2 RNA in respiratory specimens of COVID-19

Ct values (median; range) Oropharyngeal